|
| You are here: Research Programs > Clinical Research Programs > Clinical Trials > Maxamine(TM) > Application |
| Multi-Center, Randomized Open-Label Study To Evaluate The Safety And Efficacy Of Combined Immunotherapy With Subcutaneous Interleukin-2, Interferon-µ2b, And Maxamine[TM] Versus Intravenous Dacarbazine(DTIC) Alone In Patients With Advanced Malignant Melanoma
|
Online
application |
|
|